NASDAQ·Biological Products, (No Diagnostic Substances)
IPHA
Innate Pharma SA
Innate Pharma SA (ticker: IPHA) is an NASDAQ-listed biological products, (no diagnostic substances) company. DredgeCap's structured extraction of IPHA's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
IPHA Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Innate Pharma SA (IPHA) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.